Nasodren is a medication used to treat nasal polyps. It contains the active ingredient desmopressin acetate, which reduces inflammation in the nasal passages.
Developed by the pharmaceutical company Stirling Anglian in 1997
Acquired by the pharmaceutical company Uriach in 2010
A nasal spray medication that also treats nasal polyps, containing the active ingredient mometasone furoate.
A nasal spray medication that treats nasal polyps and other allergy symptoms, containing the active ingredient fluticasone propionate.
A nasal spray medication used to treat nasal polyps.
Nasal polyps are growths on the lining of the nasal passages that can cause symptoms such as congestion, runny nose, and reduced sense of smell.
Nasodren contains desmopressin acetate, which reduces inflammation in the nasal passages and shrinks nasal polyps.
Nasodren is typically used twice daily for up to 10 days.
Possible side effects of Nasodren include headache, dizziness, and nasal irritation.
There is limited information about the safety of Nasodren during pregnancy, so it should be used with caution and only if the benefits outweigh the risks.
